These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8102585)

  • 1. Neuroleptic rechallenge after neuroleptic malignant syndrome.
    Giacardi-Paty M; Bottai T; Pujalte D; Lainey E; Petit P
    Br J Psychiatry; 1993 Jul; 163():121-2. PubMed ID: 8102585
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E; Ithman M; Lauriello J
    Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant-like syndrome and acute hepatitis during tolcapone and clozapine medication.
    Blum MW; Siegel AM; Meier R; Hess K
    Eur Neurol; 2001; 46(3):158-60. PubMed ID: 11598337
    [No Abstract]   [Full Text] [Related]  

  • 5. A Case Report: Atypical Neuroleptic Malignant Syndrome on Clozapine and Mood Stabilizers.
    Amador EC; Kassam A; Hopp C; Cunningham EA
    J Clin Psychopharmacol; 2019; 39(5):518-519. PubMed ID: 31425460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A; Lesch KP
    Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic rechallenge with aripiprazole in a patient with previously documented neuroleptic malignant syndrome.
    Trutia A; Bledowski J; Pandurangi A; Kahn DA
    J Psychiatr Pract; 2008 Nov; 14(6):398-402. PubMed ID: 19057242
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M; Altavista MC; Cavallari S; Lubich L
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'.
    Weller M; Kornhuber J
    Br J Psychiatry; 1992 Dec; 161():855-6. PubMed ID: 1362370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic delirium with low-dose clozapine.
    Wilkins-Ho M; Hollander Y
    Can J Psychiatry; 1997 May; 42(4):429-30. PubMed ID: 9161772
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic malignant syndrome: a preventive program.
    Fernando ML; Manchanda R; Kirk C
    J Psychiatry Neurosci; 1992 Mar; 17(1):31-3. PubMed ID: 1349827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine, neuroleptic malignant syndrome, and pancerebellar syndrome.
    Brown TM
    Psychosomatics; 1999; 40(6):518-20. PubMed ID: 10581982
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome with risperidone.
    Levin GM; Lazowick AL; Powell HS
    J Clin Psychopharmacol; 1996 Apr; 16(2):192-3. PubMed ID: 8690838
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysphagia in the neuroleptic malignant syndrome.
    Shamash J; Miall L; Williams F; Creamer D; Robinson S; Johnston DG
    Br J Psychiatry; 1994 Jun; 164(6):849-50. PubMed ID: 7953002
    [No Abstract]   [Full Text] [Related]  

  • 15. Clozapine treatment and neuroleptic malignant syndrome.
    Doan RJ; Callaghan WD
    Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome induced by low dose aripiprazole in first episode psychosis.
    Evcimen H; Alici-Evcimen Y; Basil B; Mania I; Mathews M; Gorman JM
    J Psychiatr Pract; 2007 Mar; 13(2):117-9. PubMed ID: 17414689
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome associated with clozapine treatment.
    Tsai G; Crisostomo G; Rosenblatt ML; Stern TA
    Ann Clin Psychiatry; 1995 Jun; 7(2):91-5. PubMed ID: 8556099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S; Buckley P
    Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.
    Sewell DD; Jeste DV
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):265-9. PubMed ID: 1354002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.